FDAnews Announces: Building a World-Class Advertising and Promotion Review Program, Oct. 15-16, 2014, Philadelphia, PA

Share Article

FDA marketing scrutiny no longer is limited to magazine and TV ads. Now the agency is poking around, checking signage in tradeshow booths, checking in on Twitter and Facebook and listening to the physicians and other healthcare professionals manufacturers have paid to speak or train.

Advertising & Promotions Workshop

Advertising & Promotions Workshop

"This is normally a dry topic, but with Dale it was anything but dry. … I would definitely invite Dale back to speak again.”--Past Attendee

Building a World-Class Advertising and Promotion Review Program
**Presented by PhillyCooke Consulting and FDAnews**
Oct. 15-16, 2014 – Philadelphia, PA
http://www.fdanews.com/AdvertisingAndPromotion

Good news, millions of people are seeing manufacturers promotions, but don’t forget that the FDA is seeing them too.

FDA marketing scrutiny no longer is limited to magazine and TV ads. Now the agency is poking around, checking signage in tradeshow booths, checking in on Twitter and Facebook and listening to the physicians and other healthcare professionals manufacturers have paid to speak or train.

Darn near everything is fair game in this brave new regulatory world, even though some say FDA social-media guidances raise more questions than they answer.

And don’t forget FDA's Bad Ad program, which deputizes every healthcare professional in America to alert FDA on non-compliant promotional activities and tactics.

Face it, manufacturers need help; not with creating better ads and promotions but for making sure promotional activities aren’t magnets for warning letters.

Come to Philadelphia in October for two days of intense learning. Attendees will arrive back home with a bag full of tricks and tips to keep all marketing efforts squeaky-clean.

  • Understanding Pre-Approval Communications: Don’t get on the FDA’s or SEC’s radar screens before a product is even approved. Learn how to properly disclosure information and remain in compliance.
  • How to Maximize Disease Awareness Communications: Take away valuable tips and tricks for using disease awareness communications pre- and post-approval.
  • Hurray! It’s Approved: Building the most aggressive, but compliant campaign from first day of approval to commercial launch.
  • Assuring Promotions Meet FDA Off-Label Standards: Successfully navigating 4 major traps that can earn a warning letter fast.
  • Itching To Do More With Social Media? Discover how to get the message out there without crossing the line.

The workshop leader is Dale Cooke, principal of PhillyCooke Consulting. Mr. Cooke’s practice specializes in helping FDA-regulated companies develop compliant promotional tactics and improve the promotional review. He is the author of Effective Review & Approval of Digital Promotional Tactics and is currently at work on a book about compliant social media usage for prescription product manufacturers.

Whatever the line of endeavor — drugs, biologics, devices — if a manufacturers advertises, the FDA has its eye on them. Why risk a Form 483 or a warning letter when compliance help is so close at hand?

Conference Details:
Building a World-Class Advertising and Promotion Review Program
**Presented by PhillyCooke Consulting and FDAnews**
Oct. 15-16, 2014 – Philadelphia, PA
http://www.fdanews.com/AdvertisingAndPromotion

Tuition: $1,797

Easy Ways to Register:
Online: http://www.fdanews.com/AdvertisingAndPromotion
By phone: 888-838-5578 or 703-538-7600

About FDAnews:
FDAnews is the premier provider of domestic and international regulatory, legislative, and business news and information for executives in industries regulated by the US FDA and the European Medicines Agency. Pharmaceutical and medical device professionals rely on FDAnews' print and electronic newsletters, books and conferences to stay in compliance with international standards and the FDA's complex and ever-changing regulations.

Share article on socal media or email:

View article via:

Pdf Print

Contact Author

Michelle Butler
FDANEWS
+1 (703) 538-7665
Email >
FDAnews
Like >
Visit website